1. Home
  2. PTCT vs CVCO Comparison

PTCT vs CVCO Comparison

Compare PTCT & CVCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • CVCO
  • Stock Information
  • Founded
  • PTCT 1998
  • CVCO 1965
  • Country
  • PTCT United States
  • CVCO United States
  • Employees
  • PTCT N/A
  • CVCO N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • CVCO Homebuilding
  • Sector
  • PTCT Health Care
  • CVCO Consumer Discretionary
  • Exchange
  • PTCT Nasdaq
  • CVCO Nasdaq
  • Market Cap
  • PTCT 3.9B
  • CVCO 4.3B
  • IPO Year
  • PTCT 2013
  • CVCO N/A
  • Fundamental
  • Price
  • PTCT $50.73
  • CVCO $410.14
  • Analyst Decision
  • PTCT Buy
  • CVCO Buy
  • Analyst Count
  • PTCT 14
  • CVCO 2
  • Target Price
  • PTCT $67.64
  • CVCO $522.50
  • AVG Volume (30 Days)
  • PTCT 1.0M
  • CVCO 141.8K
  • Earning Date
  • PTCT 08-07-2025
  • CVCO 08-04-2025
  • Dividend Yield
  • PTCT N/A
  • CVCO N/A
  • EPS Growth
  • PTCT N/A
  • CVCO 12.74
  • EPS
  • PTCT 7.51
  • CVCO 20.71
  • Revenue
  • PTCT $1,772,758,000.00
  • CVCO $2,015,458,000.00
  • Revenue This Year
  • PTCT $120.38
  • CVCO $8.56
  • Revenue Next Year
  • PTCT N/A
  • CVCO $6.08
  • P/E Ratio
  • PTCT $6.60
  • CVCO $19.96
  • Revenue Growth
  • PTCT 91.12
  • CVCO 12.29
  • 52 Week Low
  • PTCT $29.02
  • CVCO $351.28
  • 52 Week High
  • PTCT $58.38
  • CVCO $549.99
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 54.87
  • CVCO 39.05
  • Support Level
  • PTCT $44.15
  • CVCO $410.32
  • Resistance Level
  • PTCT $47.61
  • CVCO $420.00
  • Average True Range (ATR)
  • PTCT 1.74
  • CVCO 12.15
  • MACD
  • PTCT -0.12
  • CVCO -1.99
  • Stochastic Oscillator
  • PTCT 81.20
  • CVCO 10.43

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About CVCO Cavco Industries Inc. When Issued

Cavco Industries Inc designs and produces factory-built homes under the Cavco Homes, Fleetwood Homes, and Palm Harbor Homes brands. It also produces modular homes, park model homes, and vacation cabins, as well as commercial structures, among others. The company operates principally in two segments: Factory-built housing, which includes wholesale and retail systems-built housing operations, and the Financial services segment, which includes manufactured housing consumer finance and insurance. Cavco receives a majority of its revenue from the Factory-built housing segment.

Share on Social Networks: